Connection

Peter Kalivas to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications Peter Kalivas has written about Dose-Response Relationship, Drug.
Peter Kalivas
Connection Strength
1.279
Dose-Response Relationship, Drug
  1. Accumbens nNOS Interneurons Regulate Cocaine Relapse. J Neurosci. 2017 01 25; 37(4):742-756.
    View in: PubMed
    Score: 0.105
  2. Effects of training and withdrawal periods on heroin seeking induced by conditioned cue in an animal of model of relapse. Psychopharmacology (Berl). 2009 May; 203(4):677-84.
    View in: PubMed
    Score: 0.060
  3. Glutamate release in the nucleus accumbens core is necessary for heroin seeking. J Neurosci. 2008 Mar 19; 28(12):3170-7.
    View in: PubMed
    Score: 0.057
  4. Extended access to cocaine self-administration enhances drug-primed reinstatement but not behavioral sensitization. J Pharmacol Exp Ther. 2007 Sep; 322(3):1103-9.
    View in: PubMed
    Score: 0.054
  5. Role of acetylcholine transmission in nucleus accumbens and ventral tegmental area in heroin-seeking induced by conditioned cues. Neuroscience. 2007 Feb 23; 144(4):1209-18.
    View in: PubMed
    Score: 0.052
  6. Development of an alcohol deprivation and escalation effect in C57BL/6J mice. Alcohol Clin Exp Res. 2006 Dec; 30(12):2017-25.
    View in: PubMed
    Score: 0.052
  7. The group II metabotropic glutamate receptor agonist, LY379268, inhibits both cocaine- and food-seeking behavior in rats. Psychopharmacology (Berl). 2006 Jun; 186(2):143-9.
    View in: PubMed
    Score: 0.050
  8. Cocaine-induced reinstatement requires endogenous stimulation of mu-opioid receptors in the ventral pallidum. J Neurosci. 2005 May 04; 25(18):4512-20.
    View in: PubMed
    Score: 0.047
  9. Homer proteins regulate sensitivity to cocaine. Neuron. 2004 Aug 05; 43(3):401-13.
    View in: PubMed
    Score: 0.044
  10. Activator of G protein signaling 3: a gatekeeper of cocaine sensitization and drug seeking. Neuron. 2004 Apr 22; 42(2):269-81.
    View in: PubMed
    Score: 0.043
  11. Repeated cocaine administration changes the function and subcellular distribution of adenosine A1 receptor in the rat nucleus accumbens. J Neurochem. 2003 Dec; 87(6):1478-84.
    View in: PubMed
    Score: 0.042
  12. Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nat Neurosci. 2003 Jul; 6(7):743-9.
    View in: PubMed
    Score: 0.041
  13. Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction. J Neurosci. 2000 Aug 01; 20(15):RC89.
    View in: PubMed
    Score: 0.034
  14. Regulation of locomotor activity by metabotropic glutamate receptors in the nucleus accumbens and ventral tegmental area. J Pharmacol Exp Ther. 2000 Jan; 292(1):406-14.
    View in: PubMed
    Score: 0.032
  15. The regulation of dopamine transmission by metabotropic glutamate receptors. J Pharmacol Exp Ther. 1999 Apr; 289(1):412-6.
    View in: PubMed
    Score: 0.031
  16. A role for nucleus accumbens glutamate transmission in the relapse to cocaine-seeking behavior. Neuroscience. 1999; 93(4):1359-67.
    View in: PubMed
    Score: 0.030
  17. HDAC5 and Its Target Gene, Npas4, Function in the Nucleus Accumbens to Regulate Cocaine-Conditioned Behaviors. Neuron. 2017 Sep 27; 96(1):130-144.e6.
    View in: PubMed
    Score: 0.028
  18. Repeated cocaine modifies the mechanism by which amphetamine releases dopamine. J Neurosci. 1997 May 01; 17(9):3254-61.
    View in: PubMed
    Score: 0.027
  19. Repeated intra-ventral tegmental area administration of SKF-38393 induces behavioral and neurochemical sensitization to a subsequent cocaine challenge. J Pharmacol Exp Ther. 1996 Jul; 278(1):384-92.
    View in: PubMed
    Score: 0.025
  20. Involvement of the ventral tegmental area in locomotion elicited from the nucleus accumbens or ventral pallidum. J Pharmacol Exp Ther. 1996 May; 277(2):1122-31.
    View in: PubMed
    Score: 0.025
  21. beta-adrenergic antagonism alters the behavioral and neurochemical responses to cocaine. Neuropsychopharmacology. 1996 Mar; 14(3):195-204.
    View in: PubMed
    Score: 0.025
  22. Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J Neurosci. 1996 Feb 15; 16(4):1550-60.
    View in: PubMed
    Score: 0.025
  23. The mediodorsal nucleus of the thalamus in rats--II. Behavioral and neurochemical effects of GABA agonists. Neuroscience. 1996 Jan; 70(1):103-12.
    View in: PubMed
    Score: 0.024
  24. Dopamine depletion augments endogenous opioid-induced locomotion in the nucleus accumbens using both mu 1 and delta opioid receptors. Psychopharmacology (Berl). 1995 Aug; 120(3):347-55.
    View in: PubMed
    Score: 0.024
  25. Individual locomotor response to novelty predicts selective alterations in D1 and D2 receptors and mRNAs. J Neurosci. 1994 Oct; 14(10):6144-52.
    View in: PubMed
    Score: 0.022
  26. Blockade of neurotensin-induced motor activity by inhibition of protein kinase. Psychopharmacology (Berl). 1994 Feb; 114(1):175-80.
    View in: PubMed
    Score: 0.021
  27. Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. J Pharmacol Exp Ther. 1993 Oct; 267(1):486-95.
    View in: PubMed
    Score: 0.021
  28. Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study. J Neurosci. 1992 Jul; 12(7):2623-32.
    View in: PubMed
    Score: 0.019
  29. Modulation of extracellular gamma-aminobutyric acid in the ventral pallidum using in vivo microdialysis. J Neurochem. 1992 Jun; 58(6):2311-20.
    View in: PubMed
    Score: 0.019
  30. Effects of d-amphetamine injected into the nucleus accumbens on ethanol reinforced behavior. Brain Res Bull. 1991 Aug; 27(2):267-71.
    View in: PubMed
    Score: 0.018
  31. Chronic N-acetylcysteine during abstinence or extinction after cocaine self-administration produces enduring reductions in drug seeking. J Pharmacol Exp Ther. 2011 May; 337(2):487-93.
    View in: PubMed
    Score: 0.017
  32. Effect of acute and daily neurotensin and enkephalin treatments on extracellular dopamine in the nucleus accumbens. J Neurosci. 1990 Sep; 10(9):2940-9.
    View in: PubMed
    Score: 0.017
  33. Preliminary evidence for a cocaine-induced embryopathy in mice. Toxicol Appl Pharmacol. 1990 Apr; 103(2):228-37.
    View in: PubMed
    Score: 0.016
  34. Blockade of enkephalinergic and GABAergic mediated locomotion in the nucleus accumbens by muscimol in the ventral pallidum. Jpn J Pharmacol. 1989 Aug; 50(4):487-90.
    View in: PubMed
    Score: 0.016
  35. Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine. J Pharmacol Exp Ther. 1988 Jun; 245(3):1095-102.
    View in: PubMed
    Score: 0.014
  36. Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat. J Pharmacol Exp Ther. 1987 Sep; 242(3):757-63.
    View in: PubMed
    Score: 0.014
  37. Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area. J Pharmacol Exp Ther. 1987 Apr; 241(1):328-37.
    View in: PubMed
    Score: 0.013
  38. Long-term neuroadaptations produced by withdrawal from repeated cocaine treatment: role of dopaminergic receptors in modulating cortical excitability. J Neurosci. 2006 Nov 22; 26(47):12308-13.
    View in: PubMed
    Score: 0.013
  39. An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30; 31(2):389-94.
    View in: PubMed
    Score: 0.013
  40. Sensitization to repeated enkephalin administration into the ventral tegmental area of the rat. I. Behavioral characterization. J Pharmacol Exp Ther. 1985 Nov; 235(2):537-43.
    View in: PubMed
    Score: 0.012
  41. Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity. J Pharmacol Exp Ther. 1983 Oct; 227(1):229-37.
    View in: PubMed
    Score: 0.010
  42. Increase in spontaneous motor activity following infusion of neurotensin into the ventral tegmental area. Brain Res. 1981 Dec 21; 229(2):525-9.
    View in: PubMed
    Score: 0.009
  43. Thyrotropin-releasing hormone: central site of action in antagonism of pentobarbital narcosis. Nature. 1979 Mar 29; 278(5703):461-3.
    View in: PubMed
    Score: 0.008
  44. Individual differences in behavior following amphetamine, GBR-12909, or apomorphine but not SKF-38393 or quinpirole. Psychopharmacology (Berl). 1994 Oct; 116(2):217-25.
    View in: PubMed
    Score: 0.006
  45. Cholecystokinin-induced suppression of locomotion is attenuated in capsaicin pretreated rats. Peptides. 1986 Jul-Aug; 7(4):587-90.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.